These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2841838)

  • 21. Changes in cardiovascular responsiveness to dopexamine and beta 1- and beta 2-adrenoceptor function after the chronic treatment of beta-adrenoceptor antagonists and agonists in anaesthetized dogs.
    Chang DH; Einstein R
    J Auton Pharmacol; 1996 Oct; 16(5):269-79. PubMed ID: 9023671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of acute haemodynamic effects of dopexamine hydrochloride, dobutamine and sodium nitroprusside in chronic heart failure.
    Baumann G; Gutting M; Pfafferott C; Ningel K; Klein G
    Eur Heart J; 1988 May; 9(5):503-12. PubMed ID: 3402466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of simultaneous alterations in preload and afterload on measurements of left ventricular contractility in patients with dilated cardiomyopathy: comparisons of ejection phase, isovolumetric and end-systolic force-velocity indexes.
    Borow KM; Neumann A; Marcus RH; Sareli P; Lang RM
    J Am Coll Cardiol; 1992 Oct; 20(4):787-95. PubMed ID: 1527288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The haemodynamic and myocardial effects of dopexamine: a new beta 2-adrenoceptor and dopaminergic agonist.
    Jaski BE; Wijns W; Foulds R; Serruys PW
    Br J Clin Pharmacol; 1986 Apr; 21(4):393-400. PubMed ID: 2871852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular actions of dopexamine in anaesthetized and conscious dogs.
    Einstein R; Abdul-Hussein N; Wong TW; Chang DH; Matthews R; Richardson DP
    Br J Pharmacol; 1994 Jan; 111(1):199-204. PubMed ID: 7912154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of dopexamine on hemodynamics and oxygen consumption after beta blockade in lambs.
    Taylor BJ; Rogers BW; Sziszak TL; Sziszak TJ
    Crit Care Med; 1993 May; 21(5):733-9. PubMed ID: 8386999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration of dopexamine, a new adrenergic agent, in cardiorespiratory failure.
    Vincent JL; Reuse C; Kahn RJ
    Chest; 1989 Dec; 96(6):1233-6. PubMed ID: 2573484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure.
    Dawson JR; Thompson DS; Signy M; Juul SM; Turnbull P; Jenkins BS; Webb-Peploe MM
    Br Heart J; 1985 Sep; 54(3):313-20. PubMed ID: 4041300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiologic mechanisms governing hemodynamic responses to positive inotropic therapy in patients with dilated cardiomyopathy.
    Borow KM; Lang RM; Neumann A; Carroll JD; Rajfer SI
    Circulation; 1988 Mar; 77(3):625-37. PubMed ID: 3342493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of adrenoceptors and dopamine receptors in modulating left ventricular diastolic function.
    Lang RM; Carroll JD; Nakamura S; Itoh H; Rajfer SI
    Circ Res; 1988 Jul; 63(1):126-34. PubMed ID: 3383371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate.
    Bayliss J; Thomas L; Poole-Wilson P
    J Cardiovasc Pharmacol; 1987 May; 9(5):551-4. PubMed ID: 2439836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopexamine hydrochloride after coronary artery bypass grafting.
    van der Starre PJ; Rosseel PM
    Am J Cardiol; 1988 Aug; 62(5):78C-82C. PubMed ID: 3261535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy.
    Carroll JD; Lang RM; Neumann AL; Borow KM; Rajfer SI
    Circulation; 1986 Oct; 74(4):815-25. PubMed ID: 3757193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cardiovascular actions of dopexamine hydrochloride, an agonist at dopamine receptors and beta 2-adrenoceptors in the dog.
    Smith GW; Hall JC; Farmer JB; Simpson WT
    J Pharm Pharmacol; 1987 Aug; 39(8):636-41. PubMed ID: 2888855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemodynamic response to dopexamine hydrochloride in postinfarction heart failure: lack of tolerance after continuous infusion.
    Svenson G; Strandberg LE; Lindvall B; Erhardt L
    Br Heart J; 1988 Dec; 60(6):489-96. PubMed ID: 3224052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting.
    MacGregor DA; Butterworth JF; Zaloga CP; Prielipp RC; James R; Royster RL
    Chest; 1994 Sep; 106(3):835-41. PubMed ID: 7915979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of hydralazine on pressure-volume and stress-volume relations in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Smucker ML; Sanford CF; Lipscomb KM
    Am J Cardiol; 1985 Oct; 56(10):690-5. PubMed ID: 4050708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the effects of dopexamine, a novel DA1 receptor and beta 2-adrenoceptor agonist, on cardiac function and splanchnic circulation in a canine model of hemorrhagic shock.
    Chintala MS; Moore RJ; Lokhandwala MF; Jandhyala BS
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):296-300. PubMed ID: 8097568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acute reduction of increased atrial natriuretic peptide level and cyclic guanosine monophosphate in patients with chronic heart failure caused by beta-adrenergic stimulation with dopexamine hydrochloride. Correlation with hemodynamic parameters].
    Stangl K; Baumann G; Weil J; Gerzer R; Kerscher M; Blömer H
    Z Kardiol; 1990 Jun; 79(6):417-23. PubMed ID: 1974099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial haemodynamic effects of intravenous dopexamine in patients with low-output heart failure.
    Tan LB; Littler WA; Murray RG
    J Cardiovasc Pharmacol; 1987 Sep; 10(3):280-6. PubMed ID: 2444775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.